Ulzep® (Ulcep®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspRAsterol for intravenous administration.
Composition:

Per 1 liter:

Active substance: Ultsep® (a fraction of polysaccharides with a molecular mass of 70 ± 10 kD, obtained from an extract of fresh potato sprouts - Solanum tuberosum L) - 0.5 g.

Excipients: sodium chloride - 9.0 g, water for injection up to 1 liter.

Description:Pthe topcoat from colorless to slightly colored, odorless.
Pharmacotherapeutic group:Peptic ulcer treatment of plant origin
ATX: & nbsp
  • Other antiulcer drugs
    • Pharmacodynamics:

    Ulzep® is a fraction from an aqueous extract of potato sprouts (Solanum tuberosum), consisting mainly of polysaccharides (including, including sucrose, arabinose, galactose, uronic acids) and a small amount of protein.

    The Ulzep® drug normalizes the physiological processes of healing the ulcerative defect by activating the regenerative and reparative processes in the mucous membrane of the stomach and duodenum, improving the spatial structure of the collagen fibers of the submucosa, and improving the trophism of the damaged area of ​​the stomach or duodenum as a result of the formation of additional blood vessels.

    Pharmacokinetics:

    The preparation contains a complex of biologically active substances, therefore it is not possible to carry out pharmacokinetic studies.

    Indications:

    In the complex therapy of peptic ulcer of the stomach and duodenum in the phase of exacerbation, regardless of the presence or absence of Helicobacter pylori infection, as well as the level of acidity of the gastric contents.

    Contraindications:

    Hypersensitivity to the components of the drug (including sucrose, arabinose, galactose, uronic acids, a protein of potatoes).

    Pregnancy, the period of breastfeeding.

    Children under 18 years.

    Pregnancy and lactation:

    The use of the drug during pregnancy and during breastfeeding is contraindicated (due to the lack of data on the safety of the drug in this category of patients).

    If it is necessary to use the drug in women during lactation, breastfeeding should be discontinued.

    Dosing and Administration:

    The drug Ulzep® should be injected intravenously slowly.

    A single dose for adults is 0.5 mg (the contents of one ampoule of 1 ml of solution).

    The course of treatment - 3 injections for 14 days (in the 1st, 7th, 14th days of treatment).

    Side effects:

    Allergic reactions, the appearance of a brief burning sensation and pain at the injection site.

    Overdose:

    Cases of overdose have not been registered to date.

    Interaction:

    Interaction with other medicinal products is not described.

    Effect on the ability to drive transp. cf. and fur:

    The drug does not affect the ability to drive vehicles, moving mechanisms and engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

    Form release / dosage:

    Solution for intravenous administration, 0.5 mg / ml.

    Packaging:

    1 ml per ampoule of neutral glass.

    3 ampoules per contour mesh package made of polyvinylchloride film.

    One contour mesh package together with instructions for use in a pack of cardboard.

    Storage conditions:

    In the dark place at a temperature of 2 to 10 ° C.

    Protect from freezing.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:On prescription
    Registration number:LP-000157
    Date of registration:13.01.2011 / 29.02.2016
    Expiration Date:Unlimited
    The owner of the registration certificate:SOLAFARM, LLCSOLAFARM, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp04.01.2017
    Illustrated instructions
      Instructions
      Up